Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Matriptase is crucial for keeping epithelial tissues healthy and functioning properly.

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Stress stops hair growth in mice by causing early hair growth phase end and harmful inflammation through a specific nerve-related pathway.

PRP treatment improves hair growth, and the device used can affect results, with some being more effective.

ECM1-modified stem cells can effectively treat liver cirrhosis.

PRP and HF-MSCs treatment improves hair growth, thickness, and density in androgenetic alopecia.

Stress increases certain chemicals in the skin and nerves, which might worsen skin conditions.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

The BMP/Smads pathway and Id2 gene control hair follicle stem cells, affecting their rest and growth phases.

Early development of hair, teeth, and glands involves specific signaling pathways and cellular interactions.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Foxi3 expression in developing teeth and hair is controlled by the ectodysplasin pathway.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

New hair can grow from large wounds in mice, but less so as they age, involving reprogramming of skin cells and specific molecular pathways.

WNT7A gene expression is higher in early stages of androgenetic alopecia, showing the role of WNT pathway, apoptosis, and inflammation in the disorder.

4-O-Methylhonokiol helps protect skin cells from growth-stopping effects of a protein by regulating growth-related pathways.

The research provides a gene-based framework for hair biology, highlighting the Hippo pathway's importance and suggesting links between hair disorders, cancer pathways, and the immune system.

Vitamin B12 may promote hair growth by affecting certain cell processes.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Adult esophageal cells can start to become like skin cells, with a key pathway influencing this change.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Researchers created a model to understand heart aging, highlighting key genes and pathways, and suggesting miR-208a as a potential heart attack biomarker.

Mouse cell exosomes help hair regrowth and wound healing by activating a specific signaling pathway.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

The research provides insights into hair follicle growth in forest musk deer by identifying key genes and pathways involved.

Particulate matter causes inflammation in hair cells, potentially harming hair growth.